Micrococcus infection in patients receiving epoprostenol by continuous infusion

Saved in:
Bibliographic Details
Published inEuropean journal of clinical microbiology & infectious diseases Vol. 22; no. 11; pp. 704 - 705
Main Authors YAP, R. L, MERMEL, L. A
Format Journal Article
LanguageEnglish
Published Berlin Springer 01.11.2003
Springer Nature B.V
Subjects
Adult
Aged
Antihypertensive Agents - adverse effects
Antihypertensive Agents - therapeutic use
Biological and medical sciences
Catheters, Indwelling - adverse effects
Catheters, Indwelling - microbiology
Cohort Studies
Epoprostenol - adverse effects
Epoprostenol - therapeutic use
Female
Follow-Up Studies
Gram-Positive Bacterial Infections - diagnosis
Gram-Positive Bacterial Infections - epidemiology
Gram-Positive Bacterial Infections - etiology
Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - drug therapy
Incidence
Infectious diseases
Infusions, Intravenous
Male
Medical sciences
Micrococcus - isolation & purification
Middle Aged
Retrospective Studies
Risk Assessment
Human
Vasodilator agent
Prostaglandin I2
Microbiology
Arachidonic acid derivatives
Antiplatelet agent
Infection
Epoprostenol
Perfusion
Bacteria
Micrococcales
Micrococcaceae
Micrococcus
Online AccessGet full text

Cover

More Information
ISSN:0934-9723
1435-4373
DOI:10.1007/s10096-003-1024-1